EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Long-Term Prognosis of Pure and Impure Tachycardiomyopathy

Giulia Stronati, Michele Alfieri, Niki Tombolesi, Alessandro Barbarossa, Samuele Principi, Federico Gullì, Arianna Massari, Gianmarco Bastianoni, Francesca Roccetti, Michela Casella, Antonio Dello Russo, Federico Guerra iD

ESC Heart Failure · 01.12.2025 · 12 (6) · 4288-4298

DOI: 10.1002/ehf2.15444 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift ESC Heart Failure, online erschienen am 09.10.2025. Verfasst von Giulia Stronati und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Marche University Hospital, Ancona, Italy. Hauptthemen laut MEDLINE: Cardiomyopathies, Stroke Volume, Heart Failure, Tachycardia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marche Polytechnic University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Tachycardia-induced cardiomyopathy (TCM) is a reversible form of heart failure (HF) driven by arrhythmias, often atrial fibrillation (AF). While reversible, TCM's long-term prognosis remains unclear, especially in comparison to HF with reduced ejection fraction (HFrEF). This study examines the prognosis of pure and impure TCM against other causes of HFrEF.

Methods

Prospective, monocentric, observational study of 456 patients hospitalized with de novo, acute decompensated HFrEF, classified into pure TCM, impure TCM, ischaemic HF and non-ischaemic HF. The primary endpoint was all-cause mortality, and the secondary endpoint was the incidence of unplanned cardiovascular hospitalisations. Sensitivity analyses were performed using propensity score matching between the four groups.

Results

During a median follow-up of 3 years (interquartile range 1.5–5.1 years), pure TCM had the highest survival rate, and ischaemic HF had the lowest (pure TCM 78.2%; impure TCM 64.8%; non-ischaemic HF 73.4%; ischaemic HF 58.5%; log-rank P < 0.0001). Pure and impure TCM presented the lowest free-from-readmission estimates over follow-up (pure TCM 43.2%; impure TCM 60.0%; non-ischaemic HF 83.2%; ischaemic HF 69.9%; log-rank P < 0.0001). An initial rhythm control strategy was associated with better overall survival in TCM (79% vs. 63%; log-rank P < 0.0001) but similar rates of unplanned hospitalization.

Conclusions

Pure TCM shows a favourable survival prognosis but high readmission rates, emphasizing the need for early rhythm control and sustained monitoring for arrhythmia recurrence. An initial rhythm control strategy seems associated with an increased survival, highlighting the importance of early recognition of arrhythmias as a culprit of HF worsening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesStroke VolumeHeart FailureTachycardiaHumansFemaleMalePrognosisProspective StudiesAgedFollow-Up StudiesMiddle AgedTime FactorsSurvival RateIncidence

Stichwörter der Autor:innen

arrhythmia‐induced cardiomyopathyatrial fibrillationheart failureprognosissurvivaltachycardiomyopathy

Autor:innen und Institutionen

  • Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Marche University Hospital, Ancona, Italy.
  • Cardiology and Intensive Care Unit, IRCCS INRCA, Ancona, Italy.
  • Cardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy.
  • Department of Odontostomatologic and Specialized Clinical Sciences, Marche Polytechnic University, Marche University Hospital, Ancona, Italy.

ORCID-Profile: Federico Guerra

Förderung

  • Marche Polytechnic University

Zitieren

APA

Stronati, G., Alfieri, M., Tombolesi, N., Barbarossa, A., Principi, S., Gullì, F., Massari, A., Bastianoni, G., Roccetti, F., Casella, M., Dello Russo, A., & Guerra, F. (2025). Long-Term Prognosis of Pure and Impure Tachycardiomyopathy. ESC Heart Failure, 12(6), 4288-4298. https://doi.org/10.1002/ehf2.15444

Vancouver

Stronati G, Alfieri M, Tombolesi N, Barbarossa A, Principi S, Gullì F, et al. Long-Term Prognosis of Pure and Impure Tachycardiomyopathy. ESC Heart Failure. 2025;12(6):4288-4298. doi:10.1002/ehf2.15444

BibTeX
@article{Stronati2025,
  author = {Stronati, Giulia and Alfieri, Michele and Tombolesi, Niki and Barbarossa, Alessandro and Principi, Samuele and Gullì, Federico and Massari, Arianna and Bastianoni, Gianmarco and Roccetti, Francesca and Casella, Michela and Dello Russo, Antonio and Guerra, Federico},
  title = {Long-Term Prognosis of Pure and Impure Tachycardiomyopathy},
  journal = {ESC Heart Failure},
  year = {2025},
  volume = {12},
  number = {6},
  pages = {4288--4298},
  doi = {10.1002/ehf2.15444}
}
Kostenlos starten →